BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31705671)

  • 21. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy.
    Fjæra LF; Indelicato DJ; Handeland AH; Ytre-Hauge KS; Lassen-Ramshad Y; Muren LP; Stokkevåg CH
    Radiother Oncol; 2022 Oct; 175():47-55. PubMed ID: 35917900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation.
    Bolsi A; Placidi L; Pica A; Ahlhelm FJ; Walser M; Lomax AJ; Weber DC
    Radiother Oncol; 2020 Aug; 149():197-204. PubMed ID: 32387488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can the mean linear energy transfer of organs be directly related to patient toxicities for current head and neck cancer intensity-modulated proton therapy practice?
    Wagenaar D; Schuit E; van der Schaaf A; Langendijk JA; Both S
    Radiother Oncol; 2021 Dec; 165():159-165. PubMed ID: 34534614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
    Paganetti H
    Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying Systematic RBE-Weighted Dose Uncertainty Arising from Multiple Variable RBE Models in Organ at Risk.
    Koh WYC; Tan HQ; Ng YY; Lin YH; Ang KW; Lew WS; Lee JCL; Park SY
    Adv Radiat Oncol; 2022; 7(2):100844. PubMed ID: 35036633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards harmonizing clinical linear energy transfer (LET) reporting in proton radiotherapy: a European multi-centric study.
    Hahn C; Ödén J; Dasu A; Vestergaard A; Fuglsang Jensen M; Sokol O; Pardi C; Bourhaleb F; Leite A; de Marzi L; Smith E; Aitkenhead A; Rose C; Merchant M; Kirkby K; Grzanka L; Pawelke J; Lühr A
    Acta Oncol; 2022 Feb; 61(2):206-214. PubMed ID: 34686122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FRoG: An independent dose and LET
    Kopp B; Fuglsang Jensen M; Mein S; Hoffmann L; Nyström H; Falk M; Haberer T; Abdollahi A; Debus J; Mairani A
    Med Phys; 2020 Oct; 47(10):5274-5286. PubMed ID: 32737870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of potentially variable RBE in liver proton therapy.
    Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
    Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposing a Clinical Model for RBE Based on Proton Track-End Counts.
    Henthorn NT; Gardner LL; Aitkenhead AH; Rowland BC; Shin J; Smith EAK; Merchant MJ; Mackay RI; Kirkby KJ; Chaudhary P; Prise KM; McMahon SJ; Underwood TSA
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):916-926. PubMed ID: 36642109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linear energy transfer painting with proton therapy: a means of reducing radiation doses with equivalent clinical effectiveness.
    Fager M; Toma-Dasu I; Kirk M; Dolney D; Diffenderfer ES; Vapiwala N; Carabe A
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1057-64. PubMed ID: 25832696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
    Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
    Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical note: Investigation of dose and LET
    Yang Y; Rwigema JM; Vargas C; Yu NY; Keole SR; Wong WW; Schild SE; Bues M; Liu W; Shen J
    Med Phys; 2022 Dec; 49(12):7428-7437. PubMed ID: 36208196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy.
    Ulrich S; Wieser HP; Cao W; Mohan R; Bangert M
    Acta Oncol; 2017 Nov; 56(11):1420-1427. PubMed ID: 28828913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors.
    Garbacz M; Cordoni FG; Durante M; Gajewski J; Kisielewicz K; Krah N; Kopeć R; Olko P; Patera V; Rinaldi I; Rydygier M; Schiavi A; Scifoni E; Skóra T; Tommasino F; Rucinski A
    Radiother Oncol; 2021 Oct; 163():143-149. PubMed ID: 34461183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.